Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Biolife Solutions Inc shares valued at $23,910,000 were purchased by Casdin Partners Master Fund, L on Jun 10 ’25. At $23.91 per share, Casdin Partners Master Fund, L acquired 1,000,000 shares.
Also, Foster Karen A. sold 251 shares, netting a total of over 5,637 in proceeds. Following the sale of shares at $22.46 each, the insider now holds 195,316 shares.
Before that, Aebersold Sarah had sold 217 shares from its account. In a trade valued at $4,874, the Chief Human Resources Officer traded Biolife Solutions Inc shares for $22.46 each. Upon closing the transaction, the insider’s holdings decreased to 217 shares, worth approximately $1.89 million.
As published in their initiating research note from H.C. Wainwright on September 30, 2024, Biolife Solutions Inc [BLFS] has been a Buy and the price target has been revised to $29. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in early April. As of July 11, 2023, Craig Hallum has initiated its “Buy” rating for BLFS. Earlier on April 25, 2022, Oppenheimer upgraded its rating. Their new recommendation was “an Outperform” for BLFS stock which previously was a “a Perform”.
Analyzing BLFS Stock Performance
During the last five days, there has been a surge of approximately 7.76%. Over the course of the year, Biolife Solutions Inc shares have dropped approximately -8.55%. Shares of the company reached a 52-week high of $29.55 on 01/30/25 and a 52-week low of $19.10 on 04/09/25.
Support And Resistance Levels for Biolife Solutions Inc (BLFS)
According to the 24-hour chart, there is a support level at 23.36, which, if violated, would cause prices to drop to 22.98. In the upper region, resistance lies at 24.47. The next price resistance is at 25.20. RSI (Relative Strength Index) is 55.95 on the 14-day chart, showing neutral technical sentiment.
